Health & Research Goals
Epithalon (Epitalon / AEDG Tetrapeptide)
Epithalon
Epithalon (also spelled Epitalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG), d…
Primary Description
Epithalon (also spelled Epitalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG), developed in the 1980s by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Originally derived from the bovine pineal gland extract epithalamin, Epithalon has become the most-researched peptide in telomere biology, with published data showing it activates telomerase and elongates telomeres in human cell lines — including surpassing the Hayflick limit in fibroblasts. The biohacker and longevity community considers it one of the premier anti-aging interventions available, used in short cyclical protocols 2–3 times per year.
Key Benefits
- Telomere lengthening
- Anti-aging
- Sleep improvement
As a very short tetrapeptide, Epithalon demonstrates better membrane permeability than longer peptides and has been shown to cross the blood-brain barrier in animal studies. Small size also facilitates tissue distribution to the pineal gland and immune organs. Lyophilized powder is highly stable when stored properly.
Demonstrated Effects
- Activates telomerase enzyme and elongates telomeres in human somatic cell lines — including surpassing the Hayflick limit in fibroblasts
- Increases telomere length in human blood cells — demonstrated in clinical studies in patients aged 60–80
- Restores and normalizes melatonin production from the aging pineal gland
- Enhances antioxidant enzyme activity: superoxide dismutase, glutathione peroxidase, glutathione-S-transferase
- Reduces chromosomal aberrations associated with aging
- Modulates immune function and thymic activity, particularly relevant in age-related immune decline
- Prospective human studies (Russian) suggest up to 28% lower all-cause mortality and reduced cardiovascular deaths over multi-year courses
- Neuroprotective and epigenetic gene expression effects documented in human stem cell models
Proposed Mechanisms of Action
1. Telomerase Activation
Epithalon induces expression of the catalytic subunit of telomerase (hTERT) in human somatic cells, reactivating telomere maintenance in telomerase-negative cell types. Once activated, telomerase elongates telomeres independently of continued peptide exposure — making short cycles sufficient for a lasting effect.
Directly addresses the hallmark of cellular aging — progressive telomere shortening. Cells with elongated telomeres have more divisions available before senescence, contributing to tissue regeneration capacity and longer healthspan.
2. Epigenetic Gene Regulation via Histone Interaction
The acidic residues glutamic acid (Glu) and aspartic acid (Asp) in AEDG provide negative charges at physiological pH that facilitate interaction with positively charged histone proteins (H1/3 and H1/6), influencing chromatin conformation and transcription accessibility.
Modulates gene expression programs associated with aging, neurogenesis, and immune function at the chromatin level — a potentially broad anti-aging mechanism beyond telomere biology alone.
3. Pineal Gland and Melatonin Restoration
Epithalon directly influences melatonin synthesis pathways and normalizes gonadotropin-melatonin relationships in aging organisms. It appears to restore pineal gland function rather than simply supplement melatonin output.
Drives improvements in circadian rhythm regulation, sleep quality, and the melatonin-dependent downstream effects on antioxidant defense, immune function, and mood.
4. Antioxidant Enzyme Upregulation
Epithalon increases activity of superoxide dismutase (SOD), glutathione peroxidase, and glutathione-S-transferase, the primary enzymatic antioxidant defense systems.
Reduces oxidative damage to DNA, proteins, and lipids — one of the primary molecular drivers of cellular aging and age-related disease.
Research Evidence & Clinical Data
Investigated Applications
Telomere Elongation and Cellular Longevity
Anecdotal: HighThe defining application that drives most community use. Biohackers use Epithalon primarily for its telomere-related effects — seeking to slow or partially reverse cellular aging at the chromosomal level. Users often track telomere length via commercial testing before and after cycles. The research basis here is stronger than most peptides: multiple published cell culture, animal, and human studies from Khavinson's group support telomerase activation.
Preclinical basis: In human fibroblasts, Epithalon induced telomerase catalytic subunit expression, increased telomerase enzymatic activity, and achieved telomere elongation beyond the Hayflick limit (passage 44 vs 34 controls). Human lymphocyte studies showed approximately 33% telomere length increase. Published in Biogerontology (Springer, 2025).
Circadian Rhythm and Sleep Restoration
Anecdotal: ModerateEpithalon's pineal gland origin underpins its role in circadian biology. Aging causes progressive decline in pineal function and melatonin output. Community members — particularly those over 50 — report improved sleep quality, more consistent sleep-wake cycles, and reduced need for supplemental melatonin after Epithalon cycles.
Preclinical basis: Epithalon directly influences melatonin synthesis and alters gonadotropin and melatonin levels in vivo. It restores pineal function rather than replacing melatonin with exogenous supplementation.
Immune Function and Age-Related Immune Decline
Anecdotal: ModerateThe Thymalin + Epithalon combination is the classic Russian longevity protocol specifically designed to address immunosenescence. Community members over 50 use this combination in autumn/winter cycles to reinforce immune competence.
Preclinical basis: Epithalon modulates IL-2 mRNA, mitogenic activity of thymocytes, and AChE/BuChE enzyme activity. Russian prospective studies documented significant all-cause mortality reduction over multi-year courses in elderly populations receiving bi-annual peptide courses.
Antioxidant and Neuroprotection
Anecdotal: EmergingCommunity members use Epithalon as part of broader neuroprotection and cognitive longevity protocols. The AEDG sequence has been shown to stimulate gene expression and protein synthesis during neurogenesis in human stem cells — an epigenetic mechanism that may have long-term cognitive implications.
Preclinical basis: Epithalon reduces oxidative stress markers, increases antioxidant enzyme activity, suppresses free radical production in the CNS, and has been shown to stimulate neurogenesis-related gene expression in human stem cell models.
Scientific References
- 1.Khavinson et al. (2020). AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during NeurogenesisMolecules (MDPI) / PMC2020
Documents epigenetic mechanism: AEDG peptide stimulates gene expression and protein synthesis in human stem cells during neurogenesis, suggesting broad anti-aging epigenetic effects.
- 2.Khavinson & Morozov (2003). Peptides of pineal gland and thymus prolong human lifeNeuro Endocrinology Letters2003
Prospective human studies reporting up to 28% reduction in all-cause mortality and significant decreases in cardiovascular deaths in elderly cohorts receiving bi-annual Epithalon/Thymalin courses over multiple years.
- 3.
- 4.Antioxidant properties of geroprotective peptides of the pineal glandArch Gerontol Geriatr2007
- 5.
Safety Profile
Common Side Effects
- Generally very well tolerated across published research — no major adverse effects reported in Russian clinical studies over decades
- Mild restlessness or vivid dreams — occasionally reported
- Mild fatigue during early cycle days
- Injection site reactions: minor redness or irritation
- Headache — rare
- Theoretical long-term risk: telomerase activation in pre-malignant cells (not observed in published literature but cannot be fully excluded)
- Minimal
Contraindications
- Active malignancy — theoretical concern: telomerase activation could theoretically support cancer cell survival (note: published research has not demonstrated increased cancer risk, and ALT activity in cancer cells vs telomerase in normal cells appears differentiated)
- Personal or family history of telomere-related cancer predisposition syndromes
- Pregnancy and breastfeeding (insufficient safety data)
- Autoimmune conditions — immune modulation effects warrant caution
- Active cancer
Pre-Use Screening Checklist
Telomerase activation is a theoretical concern in the presence of existing malignancy. While published research has not demonstrated increased oncogenic risk with Epithalon, the theoretical mechanism warrants strict avoidance in active cancer.
Commercial telomere testing (e.g., Life Length, Teloyears) provides baseline for tracking cycle-over-cycle response. Not required but valuable for biohackers quantifying anti-aging interventions.
If using primarily for sleep/circadian purposes, baseline melatonin levels help quantify pineal restoration effect.
CBC with differential, NK cell activity, and thymus-related markers provide baseline for tracking immune modulation in older users.
Legal & Regulatory Status
Not FDA approved. Research compound only in the United States. No IND or approved therapeutic application.
Not listed on WADA Prohibited List. No established performance-enhancing classification in competitive sports context.
Not approved. Research compound.
Not approved by EMA. Research compound in Western Europe. In Russia, related peptide bioregulators have pharmaceutical status. Virtually all published clinical research originates from Russian institutions.
Not TGA approved. Research compound.
Research Protocols
Dosing Protocols
Anti-aging and telomere longevity cycle
SubcutaneousExtended longevity protocol (higher dose cycles)
SubcutaneousRoutes of Administration
Subcutaneous injection
Most commonStandard approach and most reliable for bioavailability. Injected into abdominal or thigh subcutaneous tissue using insulin-type syringe.
Sub-Q injection is the established protocol from Russian clinical research. Rotate sites over the 10-day cycle.
Intravenous (IV)
Specific useSome clinical protocols in Russian research used IV administration. Not commonly self-administered.
IV administration only in supervised clinical settings. Not a standard community practice.
Reconstitution Guide
Bacteriostatic water (BAC water) preferred; sterile water acceptable for single-use
Add BAC water slowly to lyophilized AEDG powder. Swirl gently until fully dissolved. As a very small peptide, Epithalon typically dissolves rapidly and completely.
For a 50 mg vial (common packaging): add 10 mL BAC water = 5 mg/mL. A 5 mg daily dose = 1.0 mL drawn per injection.
Refrigerate at 2–8°C. Use within 28 days. Do not freeze reconstituted solution.
Store lyophilized at -20°C for long-term storage. Stable for 24+ months when properly stored. 2–8°C is acceptable for shorter periods. Protect from light.
Morning injection is most common in community protocols, though timing relative to meals is not considered critical given Epithalon's mechanism (telomerase activation, epigenetic modulation) does not depend on fasting state. Evening dosing is also used, particularly by those pairing with DSIP for sleep benefits.
Pharmacokinetics
| Half-Life | Not precisely characterized in published literature for in vivo human use. As a tetrapeptide, rapid proteolytic clearance is expected. However, the biological effects (telomerase activation, melatonin normalization) persist well beyond plasma clearance, suggesting catalytic and epigenetic mechanisms that operate independently of continued peptide presence. |
| Absorption | Subcutaneous absorption is the standard route with reliable bioavailability. The small 4-amino-acid structure facilitates membrane permeability and has been shown to cross the blood-brain barrier in animal models, enabling central effects. |
| Distribution | Distributes to multiple tissue types including pineal gland, brain, immune organs (thymus, spleen), and peripheral tissues. Acidic residues (Glu, Asp) may facilitate binding to histone proteins in cell nuclei, extending intracellular effective duration. |
| Metabolism | Proteolytic degradation by serum peptidases. Very short peptides can sometimes survive partial gastric digestion intact or as dipeptide fragments, but oral bioavailability is not well characterized. Sub-Q injection is the established delivery route. |
| Molecular Structure | Tetrapeptide with sequence Ala-Glu-Asp-Gly (AEDG). Molecular formula: C14H22N4O9. MW: 390.3 g/mol. Acidic character at physiological pH due to Glu and Asp residues facilitating histone interactions. |
Monitoring & Risk Management
Ongoing Monitoring Steps
- Telomere lengthProgressive stabilization or increase in telomere length. Decline should prompt reassessment of protocol, lifestyle factors, and overall health.Check: Before and 3–6 months after each annual cycle series
- Sleep qualityMany users report sleep improvements during and after cycles. Disrupted sleep may indicate dose timing adjustment.Check: Ongoing (subjective or wearable)
- General vitality markersBiological age markers, inflammatory markers (hs-CRP), antioxidant status, immune markers. Used to track longitudinal effect.Check: With each cycle, annual blood work
Critical Warning Signs
- Any new unexplained masses, swellings, or rapidly growing lymph nodesDiscontinue and seek full oncological evaluation. While not expected based on available research, the theoretical telomerase-cancer concern warrants prompt investigation of any such findings.Urgency: IMMEDIATE
- Autoimmune flare symptoms (joint pain, rash, fatigue) during cyclePause cycle and evaluate. Immune modulation may be activating in autoimmune-prone individuals.Urgency: Within 1 week if persistent
Featured in Stacking Protocols
Community-researched combinations involving this compound
Thymalin (Thymosin Alpha-1)
Classic Russian Longevity ProtocolComprehensive anti-aging via telomere restoration + immune system regeneration
Epithalon targets the telomere/cellular aging axis via telomerase activation; Thymalin provides direct thymic immune support, restoring T-cell function and immune competence that declines with age. Russian prospective data suggests the combination effectively doubles geroprotective outcomes vs either alone.
Epithalon 5 mg/day sub-Q for 10 days; Thymalin (or Thymosin Alpha-1) per standard protocol. Run simultaneously. 2 cycles/year, typically spring and autumn.
GHK-Cu (Copper Peptide)
Longevity StackTelomere support + immune modulation + tissue remodeling and skin rejuvenation
GHK-Cu activates over 4,000 genes related to tissue repair, anti-inflammatory processes, and collagen synthesis, complementing Epithalon's telomere/epigenetic axis. Together they address both the cellular aging (Epithalon) and tissue structural aging (GHK-Cu) dimensions.
Epithalon 5 mg sub-Q during 10-day cycles; GHK-Cu topically or sub-Q (1–2 mg/day) concurrently or continuously between cycles.
DSIP
Sleep Optimization StackCircadian and sleep restoration stack
Epithalon restores pineal melatonin production (endocrine/circadian layer); DSIP directly modulates delta-wave sleep architecture (neurophysiological layer). Together they address sleep and circadian disruption from two distinct but complementary biological levels.
Epithalon 5 mg/day sub-Q during 10-day cycles; DSIP 100–200 mcg sub-Q 2–3 hours before bed on same or adjacent evenings.
BPC-157
BPC-157 Recovery StackLongevity and tissue repair combination
Epithalon addresses deep cellular aging (telomeres, epigenetics); BPC-157 provides ongoing tissue repair, gut health, and anti-inflammatory support. Used together for a broad-spectrum healthspan optimization approach.
Epithalon 5 mg/day sub-Q for 10-day cycles 2x/year; BPC-157 250–500 mcg daily sub-Q on an ongoing or cycling basis.
Pinealon
Brain and Pineal StackCognitive longevity and neuroprotection
Pinealon (EDR tripeptide from Khavinson's group) is specifically targeted at brain neuroprotection and cognitive anti-aging, while Epithalon addresses systemic telomere biology and pineal restoration. Together they cover both systemic and brain-specific anti-aging targets.
Epithalon 5 mg + Pinealon 5–10 mg, both sub-Q, co-administered during 10-day cycles.